A Open Study to Evaluate the Performance of Dressing on Subject With High Risk of Skin Breakdown
NCT ID: NCT01354899
Last Updated: 2016-05-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2011-05-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites
NCT00137215
Study Comparing iNPWT Dressing and Devices Affect on Bioburden Levels and Skin Condition After Seven Days
NCT05559697
Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound
NCT04299126
Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds
NCT00686296
Investigation of the Clinical Performance of Biatain Fiber Ag on Burns
NCT05824026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Braden total score ≤ 12 at enrolment
* Male or female, ≥ 18 at enrolment
* No skin- breakdown
* Subject or family member is able to understand and comply with the requirements of the study, judged by the investigator
Exclusion Criteria
* Documented skin disease
* Kown allergy to any of the components in the dressing
* Previous enroled in present study
* Subject included in other ongoing clinical investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Molnlycke Health Care AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Faergemann, Professor
Role: PRINCIPAL_INVESTIGATOR
Dermatology Department Sahlgrenska University Gothenburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology Department
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Window 02
Identifier Type: -
Identifier Source: secondary_id
WINDOW 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.